Atara Biotherapeutics, Inc. (ATRA) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for…
Source: Yahoo Finance
Sector & Industry
Atara Biotherapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Atara Biotherapeutics, Inc. at a Glance
| Company | Atara Biotherapeutics, Inc. |
| Ticker | ATRA |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $9.76 |
| Market cap | $97.97M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$1.54 |
| 52-week high | $19.14 |
| 52-week low | $3.92 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.11 |
| Return on equity (ROE) | — |
| Debt-to-equity | — |
| Average volume | 66,793 |
| Shares outstanding | 10.04M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 10 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Atara Biotherapeutics, Inc.'s current P/E ratio?
- Atara Biotherapeutics, Inc. (ATRA) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Atara Biotherapeutics, Inc.'s market capitalisation?
- Atara Biotherapeutics, Inc.'s market cap is $97.97M based on our latest snapshot. See how it ranks by market cap →
- What is ATRA's 52-week range?
- Over the past 52 weeks, ATRA has traded between $3.92 and $19.14. What does the 52-week range mean? →
- How volatile is Atara Biotherapeutics, Inc. compared to the market?
- Atara Biotherapeutics, Inc. has a beta of 0.11, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Atara Biotherapeutics, Inc. pay a dividend?
- Atara Biotherapeutics, Inc. does not currently pay a dividend according to our latest data.
- What exchange is ATRA listed on?
- ATRA is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Atara Biotherapeutics, Inc. in?
- Atara Biotherapeutics, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →